A Population-Based 5-Year Cohort Study Including All Cases of Epithelial Ovarian Cancer in Western Sweden: 10-Year Survival and Prognostic Factors

被引:56
作者
Akeson, Margareth [1 ,2 ]
Jakobsen, Anne-Marie [3 ]
Zetterqvist, Britt-Marie [5 ]
Holmberg, Erik [6 ]
Braennstroem, Mats [4 ]
Horvath, Gyoergy [2 ]
机构
[1] Boras Hosp, SAS, Div Obstet & Gynecol, SE-50182 Boras, Sweden
[2] Univ Gothenburg, Sahlgrenska Acad, Dept Oncol, Gothenburg, Sweden
[3] Univ Gothenburg, Dept Pathol, Gothenburg, Sweden
[4] Univ Gothenburg, Dept Obstet & Gynecol, Gothenburg, Sweden
[5] Trollhattan Hosp, Div Obstet & Gynecol, Trollhattan, Sweden
[6] Western Sweden Hlth Care Reg, Reg Oncol Ctr, Gothenburg, Sweden
关键词
Prognostic variable; Multivariate analysis; Residual tumor; CA-125; Survival; PRIMARY CYTOREDUCTIVE SURGERY; PREOPERATIVE CA-125; RELATIVE SURVIVAL; RESIDUAL DISEASE; FLOW-CYTOMETRY; SERUM CA-125; OLDER WOMEN; DNA-PLOIDY; FOLLOW-UP; CARCINOMA;
D O I
10.1111/IGC.0b013e3181991b13
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Epithelial ovarian cancer (EOC) is the major gynecologic cancer mortality cause in Sweden. The aim of the present study was to investigate the long-term survival and prognostic factors of a complete population-based 5-year cohort of 682 patients with invasive EOC in western Sweden (population around 1.6 million). Data relating to residual tumor after surgery, FIGO stage.. grade, histopathologic subtype, ploidy status, adjuvant chemotherapy (the prepaclitaxel period), and disease state (recurrence and death) were reported to a quality register in a prospectively kept database and were controlled against the Swedish National Cancer Registry for completeness. The median follow-up durations for the prospectively collected data in the Cox analysis and for the stir-viva] analysis that was made for all patients were 81 months (range, 52-109 months) and 11.7 years (range, 8.7-14.1 years), respectively. No patient was lost to follow-up. The relative 10-year survival rate was 38.4% (95% confidence interval, 34.5%-2.8%). The median relative survival time was 4.3 years (95% confidence interval, 3.6%-5.2%). In the univariate Cox regression analysis, prognostic significances for age, stage, residual tumor, histopathologic subtype of serous cystadenocarcinoma, grade, CA-125, and ploidy status were seen. In the multivariate analysis, age, stage, residual tumor after surgery, and postoperative CA-125 were of prognostic significance. In conclusion, 4 major prognostic factors were found for EOC in this population-based cohort study that also presents nearly accurate long-term survival owing to the nonselective nature and completeness regarding patients and follow-up of the study.
引用
收藏
页码:116 / 123
页数:8
相关论文
共 57 条
[1]
Improved survival with clinical guidelines?: Evaluation of a quality register linked to clinical guidelines for ovarian cancer in the western health care region in Sweden between 1 September 1993 and 1 June 1998 [J].
Åkeson, M ;
Zetterqvist, BM ;
Holmberg, E ;
Horvath, G .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2005, 84 (11) :1113-1118
[2]
Aggressive surgical effort and improved survival in advanced-stage ovarian cancer [J].
Aletti, GD ;
Dowdy, SC ;
Gostout, BS ;
Jones, MB ;
Stanhope, CR ;
Wilson, TO ;
Podratz, KC ;
Cliby, WA .
OBSTETRICS AND GYNECOLOGY, 2006, 107 (01) :77-85
[3]
[Anonymous], 2007, CANC INC SWED 2005
[4]
AVERETTE HE, 1995, CANCER, V76, P1096, DOI 10.1002/1097-0142(19950915)76:6<1096::AID-CNCR2820760626>3.0.CO
[5]
2-4
[6]
Ovarian cancer: Changes in patterns at diagnosis and relative survival over the last three decades [J].
Barnholtz-Sloan, JS ;
Schwartz, AG ;
Qureshi, F ;
Jacques, S ;
Malone, J ;
Munkarah, AR .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 189 (04) :1120-1127
[7]
The use of cytogenetics in understanding ovarian cancer [J].
Bernardini, M ;
Weberpals, J ;
Squire, JA .
BIOMEDICINE & PHARMACOTHERAPY, 2004, 58 (01) :17-23
[8]
Bjorge T, 1998, INT J CANCER, V75, P663, DOI 10.1002/(SICI)1097-0215(19980302)75:5<663::AID-IJC1>3.3.CO
[9]
2-4
[10]
Boston RC, 2003, ADV EXP MED BIOL, V537, P353